Here we present a protocol for the direct conversion of murine embryonic fibroblasts into fully functional and stable trophoblast stem cells by ten day over-expression of Tfap2c, Gata3, Eomes and Ets2.
Trophoblast stem cells (TSCs) arise as a consequence of the first cell fate decision in mammalian development. They can be cultured in vitro, retaining the ability to self-renew and to differentiate into all subtypes of the trophoblast lineage, equivalent to the in vivo stem cell population giving rise to the fetal portion of the placenta. Therefore, TSCs offer a unique model to study placental development and embryonic versus extra-embryonic cell fate decision in vitro. From the blastocyst stage onwards, a distinct epigenetic barrier consisting of DNA methylation and histone modifications tightly separates both lineages. Here, we describe a protocol to fully overcome this lineage barrier by transient over-expression of trophoblast key regulators Tfap2c, Gata3, Eomes and Ets2 in murine embryonic fibroblasts. The induced trophoblast stem cells are able to self-renew and are almost identical to blastocyst derived trophoblast stem cells in terms of morphology, marker gene expression and methylation pattern. Functional in vitro and in vivo assays confirm that these cells are able to differentiate along the trophoblast lineage generating polyploid trophoblast giant cells and chimerizing the placenta when injected into blastocysts. The induction of trophoblast stem cells from somatic tissue opens new avenues to study genetic and epigenetic characteristics of this extra-embryonic lineage and offers the possibility to generate trophoblast stem cell lines without destroying the respective embryo.
Recently, a study comparing several approaches of mouse embryonic stem cell to trophoblast stem cells conversion has revealed that in all analyzed systems, lineage conversion remained incomplete. Instead of induced trophoblast stem cells (iTSCs) so called trophoblast stem cell-like cells have been generated retaining a memory of the cell fate of origin1. Here, we followed a different approach of iTSC generation. Similar to the direct induction of pluripotent stem cells from murine embryonic fibroblasts (MEFs) 2, iTSCs have been directly converted from differentiated somatic tissue. First, we identified 12 candidate factors inducing TSC fate when overexpressed in MEFs. Later on, the factors Tfap2c, Gata3, Eomes and Ets2 have been identified to be necessary and sufficient for the iTSC induction 3. Simultaneously, another group independently found Tfap2c, Gata3 and Eomes to be sufficient to convert MEFs into iTSCs. However, in that study, the time required for transgene expression is considerably longer compared to our study, indicating different conversion kinetics, when Ets2 is absent from the transdifferentiation cocktail 4.
Conventional fetal bovine serum (FBS) containing culture of induced and blastocyst derived trophoblast stem cells relies on the presence of factors secreted by growth-inactivated MEFs 5,6. During the iTSC induction, these factors are provided by MEFs, which lack the full combination of transgenes and are not undergoing transdifferentiation. However, once individual iTSC colonies are sub-cultured, they require media, which has been preconditioned by growth-inactivated MEFs. From there on, iTSCs can be cultured and treated like blastocyst derived TSCs according to standard protocols. Of note, in contrast to Tanaka et al. 5, we routinely culture TSCs and iTSCs without gelatinizing cell culture dishes.
All mouse experiments were conducted according to the German law of animal protection and in agreement with the approval of the local institutional animal care committees (Landesamt fuer Natur, Umwelt und Verbraucherschutz, North Rhine-Westphalia [approval ID number: AZ 84-02.04.2013.A428]).
1. Media Preparation
2. Murine Embryonic Fibroblast Derivation
3. Lentiviral Vector Production in 293T Cells
Note: All steps are carried out in laboratory space licensed to Biosafety Level 2.
4. Fibroblast Transduction with 4 Factors and mCherry Control Vector
Note: All steps are carried out in a Biosafety Level 2 facility.
5. Fibroblast to iTSC Conversion
Note: All steps are carried out in laboratory space licensed to Biosafety Level 2.
6. Isolation of Individual iTSC Lines
Note: For step 6.3 a tissue culture hood is not required. It is recommended to wipe down the inverted microscope with 70% ethanol to minimize the chances of bacterial contamination. Individual iTSC colonies can be isolated between days 21 and 28 days of transdifferentiation.
On the dish where transgene expression of the 4F is activated, cells rapidly change morphology (compare Figure 2A and B). Around day 14 – 21 distinct transdifferentiated areas emerge (two examples are given in Figure 2B and C). These primary colonies lack typical TSC morphology; however once they are sub-cultured, characteristic epithelial morphology with tight edges and bright boundaries highly reminiscent of bona fide TSCs emerges (Figure 2D). 4F-iTSCs stain positive for trophoblast transcription factors Cdx2 and Tfap2c (Figure 2E). These iTSC lines can now be used for subsequent in vitro or in vivo analyses, i.e., in vitro differentiation assays or placental chimerization experiments.
Figure 1. Timeline of MEF to iTSC Conversion. Graphical representation of transdifferentiation of MEFs into iTSCs. Please click here to view a larger version of this figure.
Figure 2. Representative Changes in Morphology During MEF to iTSC Conversion.
(A) Photomicrograph of rtTA-MEFs. (B) Photomicrograph of transdifferentiated 4F-MEFs. Example of a transdifferentiated area, highlighted in red. (C) Example 2 of a transdifferentiated colony on day 21 of transdifferentiation after ten days dox induction in 4F-MEFs. Area suitable for sub-culturing highlighted in red. (D) Photomicrograph of 4F-iTSCs after sub-culturing. All scale bars indicate 100 µm. Images were taken on an inverted microscope using a 10X lens and phase contrast. (E) Immunofluorescence staining against the transcription factors Cdx2 and Tfap2c in 4F-iTSCs. Nuclei are stained with Hoechst. Scale bars indicate 100 µm. Please click here to view a larger version of this figure.
The 4 factor (Tfap2c, Gata3, Eomes, Ets2) based transdifferentiation protocol presented here offers a reliable method to generate faithfully converted iTSCs from mouse embryonic fibroblasts. Further, the method is also applicable for post-natal tail fibroblasts, although with a drop in efficiency compared to embryonic fibroblasts 3. In general, quality of primary fibroblasts is a critical factor of transdifferentiation outcome and care should be taken to use early passage cells (passage two to three).
The strength of this protocol is the use of doxycycline-inducible vectors, which allow for temporal control of transgene expression. This enables the generation of stable iTSC lines that activate the endogenous transcription factor network, maintaining TSC fate independent of transgene expression. This is in contrast to previously published protocols, describing the induction of TSC fate from embryonic stem cells, a method that to date only yields incompletely reprogrammed trophoblast stem cell-like cells 1.
However, a known limitation of the protocol described here is the variable number of emerging transdifferentiated colonies, making it difficult to predict the transdifferentiation efficiency. These limitations are due to several highly variable factors, which are critical for the transdifferentiation outcome: the transduction efficiency of the single lentiviral vectors, the amount of proliferation of the starting cell population, and the amount of cell death during transdifferentiation. Under some circumstances transdifferentiated iTSC colonies fail to emerge. In this case media and reagents should be tested for their ability to support genuine TSC culture, before their use in iTSC generation. Additionally, transduction with the 4F can be titrated, since too high amounts of transgene expression lead to cell death. In general, sub-culturing of individual iTSC lines requires some practice. In the event that difficulties with sub-culture of iTSCs occur (i.e., sub-cultured cells fail to maintain self-renewal and instead spontaneously differentiate), single isolated colonies can be alternatively plated on dishes with 50% cell density of growth inactivated feeder cells to support growth and attachment of cells. The iTSC lines can be then gradually weaned from feeders during subsequent passaging. Of note, we did not succeed in directly converting MEFs into iTSCs using defined TX medium conditions, since TX medium only supports established iTSC/TSC lines.
So far, the protocol for iTSC induction from fibroblasts is only established for murine cells. Hence, it will now be of great interest to adapt this protocol to other species and enable derivation of iTSC lines from human or other model systems. Further, analysis of the precise mechanisms of fibroblast to iTSC conversion will offer new insights into the nature of the somatic versus extra-embryonic lineage barrier and aid in understanding principles of cell fate determination during normal and pathological development.
The authors have nothing to disclose.
Doxycycline hyclate | Sigma-Aldrich | D9891-10G | Dissolve in sterile PBS, prepare 2 mg/ml stock solution. Store aliquots at -20°C |
Chloroquine diphosphate salt | Sigma-Aldrich | C6628-25G | Prepare 25 mM stock solution in sterile cell culture grade water. Store aliquots at -20°C |
Polybrene (Hexadimethrine bromide) | Sigma-Aldrich | 107689-10G | Prepare 8 mg/ml stock solution in sterile cell culture grade water. Store aliquots at -20°C |
human recombinant Fibroblast Growth Factor 4 | ReliaTech | 300-131L | Dissolve in sterile 0.1% BSA in PBS, prepare 25 µg/ml stock solution. Store aliquots at -80°C |
Heparin sodium salt | Sigma-Aldrich | H3149-10KU | Prepare 1 mg/ml stock solution by dissolving in sterile PBS. Store aliquots at -80°C |
ProFection Mammalian Transfection System | Promega | E1200 | |
PBS, no calcium, no magnesium | ThermoFisher Scientific | 1419-094 | |
DMEM (1x) + GlutaMAX | ThermoFisher Scientific | 31966-021 | |
RPMI 1640, no glutamine | ThermoFisher Scientific | 31870-025 | |
Advanced DMEM (1x) | ThermoFisher Scientific | 12491-015 | |
Trypsin-EDTA (0.05%), phenol red | ThermoFisher Scientific | 25300-054 | |
Poly-L-lysine | Sigma-Aldrich | P4707 | |
Fetal bovine serum | Hyclone | SH30071.03IR | |
Surfactant-free cellulose acetate-membrane filter | Corning | 431220 | |
Non-essential amino acids | ThermoFisher Scientific | 11140-035 | |
Penicillin Streptomycin | ThermoFisher Scientific | 15140-122 | |
Sodium Pyruvate | ThermoFisher Scientific | 11360-039 | |
L-glutamine | ThermoFisher Scientific | 25030-24 | |
2-Mercaptoethanol | ThermoFisher Scientific | 31350-010 | |
Dimethyl sulfoxide (DMSO), cell culture grade | Panreac AppliChem GmbH | A3672,0100 | |
pLV-tetO-Tfap2c | Addgene | 70269 | |
pLV-tetO-Gata3 | Addgene | 70270 | |
pLV-tetO-Eomes | Addgene | 70271 | |
pLV-tetO-Ets2 | Addgene | 70272 | |
pLV-tetO-mCherry | Addgene | 70273 | |
psPAX2 | Addgene | 12260 | |
pMD2.G | Addgene | 12259 | |
FUdeltaGW-rtTA | Addgene | 19780 | |
Mice B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae/J 7 | JAX Mice | 6965 | |
129S2SV | Charles River | 129 |